Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Prostate Specific Antigen (PSA) Test Industry In 2025?
The prostate specific antigen (psa) test market size has seen substantial growth recently. This market is set to expand from $4.15 billion in 2024 to $4.65 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.9%. The drivers behind this historical expansion include greater awareness, an aging demographic, progress in medical science, updated clinical recommendations, and developments in pharmaceuticals.
The prostate specific antigen (psa) test market is projected for substantial expansion in the coming years, reaching $7.27 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. This growth during the forecast period is driven by factors such as enhanced test accuracy, the adoption of personalized medicine strategies, and an increasing global aging population. Key trends anticipated in the forecast period involve a move towards combining biomarkers, continuous technological innovations, the rise of point-of-care testing, greater integration of digital health solutions, and an increased emphasis on early detection and preventative measures.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp
What Are The Key Drivers Of Growth In The Prostate Specific Antigen (PSA) Test Market?
The expanding occurrence of prostate cancer is projected to stimulate the growth of the prostate-specific antigen (PSA) test market moving forward. Prostate cancer is a medical condition where malignant cells originate in the prostate gland, identified as a component of the male and female reproductive systems. The prostate-specific antigen (PSA) test is frequently employed as a screening method for prostate cancer in men. This test quantifies the level of PSA in the bloodstream, thereby assisting in early detection and risk assessment. For instance, in March 2023, based on reports from the American Society of Clinical Oncology (ASCO), a US-based professional oncology organization, an estimated 288,300 men were diagnosed with prostate cancer in the US, and roughly 34,700 people died in 2023. Thus, the escalating prevalence of prostate cancer is propelling the development of the prostate-specific antigen (PSA) test market.
What Are The Major Segment Types Covered In The Prostate Specific Antigen (PSA) Test Market?
The prostate specific antigen (psa) testmarket covered in this report is segmented –
1) By Type: Clinical Laboratory Improvement Amendments (CLIA); Enzyme-Linked Immunosorbent Assay (ELISA); Fluorescence Immunoassay (FIA); Other Types
2) By Application: Screening; Post-Treatment Monitoring; Other Applications
3) By End User: Hospitals; Diagnostic Centers; Research Institutes; Other End Users
Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests; Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits; Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA; Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA); Radioimmunoassay (RIA)
What Trends Are Expected To Drive The Prostate Specific Antigen (PSA) Test Market?
Technological advancements are emerging as a prominent trend gaining traction in the prostate-specific antigen (PSA) test market. Major companies active in the prostate-specific antigen (PSA) test market are developing sophisticated screening test tools to maintain their market standing. For example, in February 2023, LynxDx Inc., a US-based diagnostic company, introduced MyProstateScore 2.0, a non-invasive urine test designed for prostate cancer screening. This innovative test utilizes a blend of 18 biomarkers, including the novel gene fusion T2:ERG, to offer a personalized risk assessment for every patient. Additionally, this screening test delivers highly accurate, stratified risk assessment insights to guide clinical decisions for patients presenting with elevated prostate-specific antigen (PSA) or abnormal digital rectal exam (DRE) findings. Moreover, it possesses the potential to enhance prostate cancer screening and treatment strategies.
Which Global Market Leaders Are Shaping The Future Of The Prostate Specific Antigen (PSA) Test Sector?
Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The Prostate Specific Antigen (PSA) Test Market?
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Prostate Specific Antigen (PSA) Test Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp
Browse Through More Reports Similar to the Global Prostate Specific Antigen (PSA) Test Market 2025, By The Business Research Company
Prostate Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
Test And Measurement Equipment Global Market Report 2025
Testosterone Replacement Therapy Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model